Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influsplit SSW Immunogenicity and Reactogenicity in Adults
NCT00306943Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Primary completion
- Aug 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Fluarix in influenza, sponsored by GSK. Primary endpoint: Haemagglutination inhibiting antibodies. Started Jul 2005; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00306943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306943.